Thank you to all of our partners for your continued support, and for joining us on our mission to improve lung health in Canada. Your generous contributions are helping to ensure that much-needed supports and services are put in place, leading to faster diagnosis, better treatment, and better outcomes for those struggling to breathe.
Thanks to our partners, lung health starts now.
Recognition below reflects support for the fiscal year ended March 31, 2026. Partners are listed alphabetically within each giving level.
$200,000+
Health Canada — Substance Use and Addictions Program
$100,000 – $199,999
AstraZeneca Canada
Supporting our work to ensure no one loses a loved one to asthma. Advancing policy change to improve health outcomes for Canadians living with lung disease.
GSK Canada
Putting patients first to advance policy change and improve health outcomes for Canadians living with lung disease.
Merck Canada
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance.
Sanofi Canada
Helping us improve vaccination rates so older adults stay healthy and maintain their independence. Putting patients first to advance policy change and improve health outcomes for Canadians living with lung disease.
$75,000 – $99,999
The Mitchell and Kathryn Baran Family Foundation
Investing in the research and programs that help Canadians living with lung disease breathe easier.
Trudell Medical International & Trudell Healthcare Solutions
Advancing policy change to improve health outcomes for Canadians living with lung disease and supporting the community-based care that helps Canadians breathe easier at home.
$50,000 – $74,999
Kenvue Canada
Supporting Canadians who want to quit smoking or vaping and helping them take the first step toward better lung health.
Pfizer Canada
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance. Helping us improve vaccination rates so older adults stay healthy and maintain their independence. Advancing policy change to improve health outcomes for Canadians living with lung disease. Funding critical research in infectious lung disease.
$25,000 – $49,999
Boehringer Ingelheim Canada
Supporting our work in keeping those living with COPD out of hospital and living their lives to the fullest. Advancing policy change to improve health outcomes for Canadians living with lung disease.
Cancer Research Society
Funding the lung cancer research that leads to earlier detection, better treatment and more time for people living with the disease.
Global Allergy & Airways Patient Platform (GAAPP)
A global umbrella organization for patients with airways, allergic and atopic disease — funding the work that helps Canadians breathe easier and connecting our patients’ voices to a worldwide movement.
Janssen
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance. Advancing policy change to improve health outcomes for Canadians living with lung disease.
ProResp
An Ontario home respiratory care provider, helping people with lung disease breathe easier at home — and investing in the research and education that will help the next generation of patients do the same.
Research Institute of St. Joseph's Hospital
Advancing the research that leads to better outcomes for people living with lung disease.
$10,000 – $24,999
Amgen Canada
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance.
Baker Foundation
Partnering on a common goal of improving the lung health of Canadians by investing in communities across Ontario.
Bristol Myers Squibb Canada
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance.
David J.D. Harris Foundation
Carrying forward a family’s commitment to better lung health for Ontarians.
Gear Foundation
Funding community programs that help Ontarians breathe easier.
Hepburn Engineering Inc.
An Ontario manufacturer investing in the lung health of the communities where its people live and work.
Pharmacosmos
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance.
Roche Canada
Breaking down the stigma associated with lung cancer to give those living with the disease a fighting chance. Funding critical programs to improve outcomes for people living with COPD.
$5,000 – $9,999
Bayer Inc.
Supporting the programs that help Canadians manage their lung disease and stay out of hospital.
Up to $4,999
Air-Serv Canada · BIT · Caius Medical · Edelman · Fantech/REM · Jewish Foundation of Greater Toronto · John Ernewein Ltd. · Kaz/Helen of Troy · Krilavicius Family Foundation · Linde Canada · Methapharm · Seqirus Canada Inc. · Wealthy Unicorn
Partner with us. One in five Canadians lives with lung disease.
Corporate and foundation partnership funds the research, advocacy and programs that help them breathe easier.
Contact Elan Gardner, Director, Partnership & Social Impact — egardner@lunghealth.ca
